Assessing Viking Therapeutics (VKTX) Valuation As Obesity Trial Optimism Meets Richer Balance Sheet Ratios [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Viking Therapeutics (VKTX) has recently drawn investor attention after its shares closed at US$35.20, with return figures across the past week, month and past 3 months providing a fresh snapshot of sentiment. See our latest analysis for Viking Therapeutics. Recent trading has been choppy, with a 1 day share price return of a 0.87% decline, in contrast to a 30 day share price return of 8.88% and a 1 year total shareholder return of 47.03%. This suggests that momentum has cooled in the near term but remains stronger over a longer horizon. If you are weighing Viking Therapeutics against other opportunities in healthcare, this may be a useful time to scan for peers using our healthcare focused AI stock screener, including 37 healthcare AI stocks With Viking Therapeutics still loss making, a value score of 2 and shares at US$35.20, are investors looking at an undervalued clinical pipeline, or has the market already priced in the potential for future growth? Most Popular Narrativ
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Better Long-Term Buy: Eli Lilly or Viking Therapeutics? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026? [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics to Participate at Upcoming Investor ConferencesPR Newswire
- Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 2/11/26 - Miss
VKTX
Sec Filings
- 4/1/26 - Form ARS
- 4/1/26 - Form DEFA14A
- 4/1/26 - Form DEF
- VKTX's page on the SEC website